|Bid||295.52 x 800|
|Ask||295.88 x 1100|
|Day's range||288.92 - 298.94|
|52-week range||195.50 - 314.00|
|Beta (5Y monthly)||0.40|
|PE ratio (TTM)||44.12|
|Earnings date||04 Aug 2022|
|Forward dividend & yield||3.92 (1.37%)|
|Ex-dividend date||13 May 2022|
|1y target est||304.28|
Radius (RDUS) and partner Menarini announce data from a late-stage study on breast cancer drug.
Eli Lilly, Novo Nordisk, Merck, and Glaxo are part of Zacks Industry Outlook article.
FDA grants emergency approval to Pfizer's COVID-19 vaccine for use in children 5- to 11-year old and approves Lilly's (LLY) novel diabetes treatment, Mounjaro (tirzepatide).